AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • August 6th, 2021 • Cronos Group Inc. • Medicinal chemicals & botanical products • Delaware
WHEREAS the Executive previously entered into an employment agreement with Hortican, another wholly owned subsidiary of Cronos Group, in July 2019, which the parties considered to be operational (the “Original Agreement”);
EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”)Option Award Agreement • August 6th, 2021 • Cronos Group Inc. • Medicinal chemicals & botanical products • Delaware
WHEREAS the Company wishes to engage the services of the Executive in the position of Chief Financial Officer of Cronos Group;
Jerry Barbato At the Address on file with the CompanyLetter Agreement • August 6th, 2021 • Cronos Group Inc. • Medicinal chemicals & botanical products • Delaware
This letter agreement (this “Letter Agreement”), effective as of August 9, 2021 (the “Effective Date”), sets forth the terms and conditions of our agreement regarding the separation of your employment with Hortican Inc., a corporation organized under the federal laws of Canada (the “Company”). Capitalized terms used in this Letter Agreement that are not defined herein have the meanings set forth in your employment agreement with the Company, dated as of April 2, 2019 (the “Employment Agreement”).
